Regeneron Pharmaceuticals, Inc. Market Cap
Data as of June 01, 2026
Market Cap
$64.45B
Stock Price
$614.78
Shares Outstanding
$103M
Classification
Large Cap
How It's Calculated
$64.45B = $614.78 × $103M
What This Means
Regeneron Pharmaceuticals, Inc. has a market capitalization of $64.45B, classifying it as Large Cap — a major company by market standards. Market cap represents the total value of all outstanding shares and is a key indicator of a company's size.
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector, specifically in Biotechnology. With a market capitalization of about $64.45B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $614.78, within a 52-week range of $476.49 to $821.11 (-25.1% from the high, +29.0% from the low). Beta of 0.30 indicates relatively lower volatility versus the market.
Trailing profit margin is about 29.6%, signaling a strong profit margin relative to many peers.
Understanding This Metric
Market capitalization sums the market value of all outstanding shares. It helps classify Regeneron Pharmaceuticals, Inc. by size — mega-cap, large-cap, and mid-cap stocks tend to have different liquidity, volatility, and index inclusion profiles. Size alone does not determine quality, but it frames risk and how widely the stock is held.
Sector Comparison
Among Healthcare names on our S&P 100 coverage, Regeneron Pharmaceuticals, Inc.'s market cap of $64.45B can be compared with peers such as LLY ($985.37B), JNJ ($542.42B), UNH ($345.38B). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.
Key Takeaways
- REGN is grouped in the Healthcare sector for peer comparisons.
- Recent beta of 0.30 suggests lower-than-market price sensitivity.
- Trailing profit margin of 29.6% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for REGN.
Calculated Market Cap
$63.34B
Sector
Healthcare
Other REGN Metrics
Frequently Asked Questions
What is REGN's market capitalization?
Market cap is the total market value of all outstanding shares. Regeneron Pharmaceuticals, Inc.'s market cap is about $64.45B on this page's data date.
Is REGN a mega/large/mid/small cap?
With roughly $64.45B in market cap, Regeneron Pharmaceuticals, Inc. falls in the large-cap category in our size buckets (mega ≥$200B, large ≥$10B, mid ≥$2B). Size affects liquidity, index weight, and typical volatility.
How does market cap relate to REGN's risk profile?
Larger caps tend to have broader analyst coverage and deeper trading; smaller caps can offer growth but with higher idiosyncratic risk. Use market cap together with debt, cash flow, and Healthcare position — not alone.
Calculate the market cap for any stock with our free calculator.
Open Market Cap Calculator →